129 related articles for article (PubMed ID: 11121797)
1. PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.
Ikeda Y; Young LH; Scalia R; Ross CR; Lefer AM
Cardiovasc Res; 2001 Jan; 49(1):69-77. PubMed ID: 11121797
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.
Omiyi D; Brue RJ; Taormina P; Harvey M; Atkinson N; Young LH
J Pharmacol Exp Ther; 2005 Aug; 314(2):542-51. PubMed ID: 15878997
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release.
Young LH; Ikeda Y; Lefer AM
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):107-14. PubMed ID: 11523308
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-zeta inhibition exerts cardioprotective effects in ischemia-reperfusion injury.
Phillipson A; Peterman EE; Taormina P; Harvey M; Brue RJ; Atkinson N; Omiyi D; Chukwu U; Young LH
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H898-907. PubMed ID: 15792991
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism.
Young LH; Ikeda Y; Lefer AM
Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2489-95. PubMed ID: 11356603
[TBL] [Abstract][Full Text] [Related]
6. Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion.
Young LH; Ikeda Y; Scalia R; Lefer AM
J Pharmacol Exp Ther; 2000 Oct; 295(1):37-43. PubMed ID: 10991958
[TBL] [Abstract][Full Text] [Related]
7. Gö 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion.
Peterman EE; Taormina P; Harvey M; Young LH
J Cardiovasc Pharmacol; 2004 May; 43(5):645-56. PubMed ID: 15071351
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
Lefer AM; Campbell B; Shin YK; Scalia R; Hayward R; Lefer DJ
Circulation; 1999 Jul; 100(2):178-84. PubMed ID: 10402448
[TBL] [Abstract][Full Text] [Related]
9. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.
Young LH; Ikeda Y; Scalia R; Lefer AM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1453-9. PubMed ID: 11009429
[TBL] [Abstract][Full Text] [Related]
10. Effects of a metalloproteinase that truncates P-selectin glycoprotein ligand on neutrophil-induced cardiac dysfunction in ischemia/reperfusion.
Lefer AM; Campbell B; Shin YK
J Mol Cell Cardiol; 1998 Dec; 30(12):2561-6. PubMed ID: 9990528
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
Campbell B; Chuhran CM; Lefer DJ; Lefer AM
Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):529-34. PubMed ID: 10599051
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart.
Campbell B; Adams J; Shin YK; Lefer AM
J Mol Cell Cardiol; 1999 Feb; 31(2):467-76. PubMed ID: 10093058
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart.
Campbell B; Shin YK; Scalia R; Lefer AM
Cardiovasc Res; 1998 Aug; 39(2):393-400. PubMed ID: 9798524
[TBL] [Abstract][Full Text] [Related]
15. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism.
Ikeda Y; Young LH; Scalia R; Lefer AM
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):563-71. PubMed ID: 11196344
[TBL] [Abstract][Full Text] [Related]
17. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
Gonon AT; Wang QD; Pernow J
Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion.
Pabla R; Buda AJ; Flynn DM; Blessé SA; Shin AM; Curtis MJ; Lefer DJ
Circ Res; 1996 Jan; 78(1):65-72. PubMed ID: 8603507
[TBL] [Abstract][Full Text] [Related]
19. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins.
Lefer AM; Campbell B; Scalia R; Lefer DJ
Circulation; 1998 Sep; 98(13):1322-8. PubMed ID: 9751682
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation.
Shandelya SM; Kuppusamy P; Weisfeldt ML; Zweier JL
Circulation; 1993 Feb; 87(2):536-46. PubMed ID: 8381059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
